financetom
Business
financetom
/
Business
/
Elon Musk's SpaceX wins $152 mn NASA contract to launch weather satellites
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elon Musk's SpaceX wins $152 mn NASA contract to launch weather satellites
Sep 13, 2021 10:38 AM

Elon Musk-led SpaceX has won a $152 million contract from NASA to launch geostationary weather satellites as part of the Geostationary Operational Environmental Satellite-U (GOES-U) mission.

These satellites will help predict thunderstorms, fog, tornadoes, flash floods, hurricanes and other weather conditions. GOES satellites have been used for monitoring dust storms, volcanic eruptions and forest fires, said NASA.

“The Geostationary Operational Environmental Satellite-U (GOES-U) mission will provide advanced imagery and atmospheric measurements of Earth’s weather, oceans, and environment, as well as real-time mapping of total lightning activity and improved monitoring of solar activity and space weather,” NASA said in a statement.

Starting from April 2024, Space Exploration Technologies or SpaceX will launch satellites into the orbit on a Falcon Heavy rocket from the Kennedy Space Center in Florida. Considered as the most powerful operational space launch vehicle in the world, the 23-storey Falcon Heavy delivered its first commercial payload into the orbit in 2019. Operated by the National Oceanic and Atmospheric Administration, GOES-U is the fourth and final spacecraft in the GOES-R Series of geostationary weather satellites.

Also read: NASA halts SpaceX work on lunar lander after Blue Origin lawsuit

United Launch Alliance, that earlier launched satellites from the series, withdrew itself from the bid as it did not have vehicles available to launch the satellites, Space News reported.

The SpaceX contract value is less than the $165.7 million contract awarded to United Launch Alliance in December 2019 for the GOES-T launch.

This is not the first big-budget contract SpaceX has got from NASA. It already has in its kitty a $178-million contract from the space agency to explore living conditions in Jupiter’s icy moon Europa. The Europa Clipper mission will also be launched on a Falcon Heavy rocket in October 2024.

SpaceX is one of the biggest private players in aerospace and is currently preparing to launch the first all-civilian crew for three days.

Also read: SpaceX has shipped 1 lakh Starlink terminals in 14 countries, tweets Elon Musk

(Edited by : Shoma Bhattacharjee)

First Published:Sept 13, 2021 7:38 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tequila giant Becle sees 2024 net sales growth in low single digits
Tequila giant Becle sees 2024 net sales growth in low single digits
Oct 24, 2024
MEXICO CITY, Oct 24 (Reuters) - Mexican distiller Becle , the world's largest tequila maker, sees 2024 net sales growth in the low single digits at a constant currency rate, Chief Financial Officer Rodrigo de la Maza said on a conference call on Thursday. ...
Humana, Longevity Health Expand Access to Special Needs Plans
Humana, Longevity Health Expand Access to Special Needs Plans
Oct 24, 2024
10:54 AM EDT, 10/24/2024 (MT Newswires) -- Humana (HUM) and Longevity Health said Thursday that eligible residents of long-term care facilities in Indiana, Iowa, Kentucky, Louisiana, New Mexico, Tennessee, Washington and West Virginia will get access to Humana Together in Health plans beginning next year. Humana Together in Health, currently available in Georgia, South Carolina, Texas, Virginia, and parts of...
3 Health Care Stocks Moving In Thursday's Intraday Session
3 Health Care Stocks Moving In Thursday's Intraday Session
Oct 25, 2024
Gainers Viking Therapeutics ( VKTX ) stock moved upwards by 22.8% to $74.16 during Thursday's regular session. The company's market cap stands at $8.2 billion. As per the news, the Q3 earnings report came out yesterday. Losers Intellia Therapeutics ( NTLA ) stock declined by 18.3% to $16.29 during Thursday's regular session. The market value of their outstanding shares is...
AbbVie's Emraclidine Phase 2 Trial Data in Q4 Present Major Catalyst, UBS Says
AbbVie's Emraclidine Phase 2 Trial Data in Q4 Present Major Catalyst, UBS Says
Oct 24, 2024
11:47 AM EDT, 10/24/2024 (MT Newswires) -- AbbVie's ( ABBV ) expected Q4 report on its phase 2 Empower 1 and 2 studies of emraclidine in schizophrenia will be a major catalyst, UBS said in a note to clients Thursday. UBS said that due to the need for new schizophrenia treatments, a statistically significant benefit across both trials should be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved